Detailed Research: Economic Perspectives on OUTFRONT Media, Limoneira, Papa John's International, Everi, Premier, and Summit Therapeutics — What Drives Growth in Today's Competitive Landscape

World News: . []

NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of OUTFRONT Media Inc. (NYSE:OUT), Limoneira Co (NASDAQ:LMNR), Papa John's International, Inc. (NASDAQ:PZZA), Everi Holdings Inc. (NYSE:EVRI), Premier, Inc. (NASDAQ:PINC), and Summit Therapeutics PLC (NASDAQ:SMMT), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

The new research reports from Fundamental Markets, available for free download at the links above, examine OUTFRONT Media Inc. (NYSE:OUT), Limoneira Co (NASDAQ:LMNR), Papa John's International, Inc. (NASDAQ:PZZA), Everi Holdings Inc. (NYSE:EVRI), Premier, Inc. (NASDAQ:PINC), and Summit Therapeutics PLC (NASDAQ:SMMT) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

-----------------------------------------

For the three months ended September 30th, 2018 vs September 30th, 2017, OUTFRONT Media reported revenue of $414.20MM vs $392.40MM (up 5.56%) and analysts estimated basic earnings per share $0.33 vs $0.36 (down 8.33%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, OUTFRONT Media reported revenue of $1,520.50MM vs $1,513.90MM (up 0.44%) and analysts estimated basic earnings per share $0.90 vs $0.66 (up 36.36%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.60. The estimated EPS forecast for the next fiscal year is $2.21 and is expected to report on February 26th, 2019.

To read the full OUTFRONT Media Inc. (OUT) report, download it here:

-----------------------------------------

For the three months ended July 31st, 2018 vs July 31st, 2017, Limoneira reported revenue of $39.95MM vs $40.40MM (down 1.10%) and analysts estimated basic earnings per share $0.51 vs $0.53 (down 3.77%). For the twelve months ended October 31st, 2017 vs October 31st, 2016, Limoneira reported revenue of $121.31MM vs $111.79MM (up 8.52%) and analysts estimated basic earnings per share $0.42 vs $0.52 (down 19.23%). Analysts expect earnings to be released on January 14th, 2019. The report will be for the fiscal period ending October 31st, 2018. Reported EPS for the same quarter last year was -$0.19. The estimated EPS forecast for the next fiscal year is $0.93 and is expected to report on January 14th, 2019.

To read the full Limoneira Co (LMNR) report, download it here:

-----------------------------------------

For the three months ended September 30th, 2018 vs September 30th, 2017, Papa John's International reported revenue of $364.01MM vs $431.71MM (down 15.68%) and analysts estimated basic earnings per share -$0.41 vs $0.61. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Papa John's International reported revenue of $1,783.36MM vs $1,713.62MM (up 4.07%) and analysts estimated basic earnings per share $2.86 vs $2.76 (up 3.62%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.65. The estimated EPS forecast for the next fiscal year is $1.68 and is expected to report on February 26th, 2019.

To read the full Papa John's International, Inc. (PZZA) report, download it here:

-----------------------------------------

For the three months ended September 30th, 2018 vs September 30th, 2017, Everi reported revenue of $120.33MM vs $247.32MM (down 51.35%) and basic earnings per share $0.03 vs -$0.06. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Everi reported revenue of $974.95MM vs $859.46MM (up 13.44%) and analysts estimated basic earnings per share -$0.78 vs -$3.78. Analysts expect earnings to be released on March 12th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.17. The estimated EPS forecast for the next fiscal year is $0.07 and is expected to report on March 12th, 2019.

To read the full Everi Holdings Inc. (EVRI) report, download it here:

-----------------------------------------

For the three months ended June 30th, 2018 vs June 30th, 2017, Premier reported revenue of $433.96MM vs $403.10MM (up 7.66%) and analysts estimated basic earnings per share -$5.95 vs -$6.45. For the twelve months ended June 30th, 2018 vs June 30th, 2017, Premier reported revenue of $1,661.26MM vs $1,454.67MM (up 14.20%) and analysts estimated basic earnings per share $3.57 vs $1.54 (up 131.82%). Analysts expect earnings to be released on February 4th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.46. The estimated EPS forecast for the next fiscal year is $2.74 and is expected to report on August 20th, 2019.

To read the full Premier, Inc. (PINC) report, download it here:

-----------------------------------------

For the three months ended July 31st, 2018 vs July 31st, 2017, Summit Therapeutics reported revenue of $50.51MM vs $25.01MM (up 101.97%) and analysts estimated basic earnings per share $2.13 vs $1.15 (up 85.14%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Summit Therapeutics reported revenue of $33.08MM vs $3.08MM (up 973.16%) and analysts estimated basic earnings per share -$0.70 vs -$2.32. Analysts expect earnings to be released on December 5th, 2018. The report will be for the fiscal period ending October 31st, 2018. The reported EPS for the same quarter last year was -$0.20. The estimated EPS forecast for the next fiscal year is -$1.74 and is expected to report on April 10th, 2019.

To read the full Summit Therapeutics PLC (SMMT) report, download it here:

-----------------------------------------

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

More news and information about Fundamental Markets

Published By:

Globe Newswire: 12:30 GMT Friday 9th November 2018

Published: .

Search for other references to "detailed" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us